The Digestive Diseases Research Core Center at the University of North Carolina seeks five years of additional support to study gastrointestinal biology and the pathophysiology of gastrointestinal diseases. In the first three of four years of Center funding under the initial award, four major areas of research have emerged in this Center: (1) intestinal water and electrolyte transport, (2) gastrointestinal inflammation and immunology, (3) gastrointestinal epithelial damage, growth, development and repair, and (4) gastrointestinal epidemiology. Interactive research among 34 Investigators from 15 Departments in 5 Schools located in two separate Universities (UNC-CH and NCSU) has been facilitated by two core laboratories (Barrier Intact Animal Facility at NCSU and Biostatistics Core at UNC-CH) and by a pilot/feasibility (P/F) program that has funded (in the first three years) 15 separate studies. Proposed changes in the Center for the next five years include: (1) changing the name from the Core Center in Diarrheal Diseases (CCDD) to the Center for Gastrointestinal Biology and Disease (CGIBD), (2) maintaining the Biostatistics Core, splitting the Barrier Intact Animal Facility into two cores (Gnotobiotic Animal Core and Barrier Intact Piglet Facility) and adding a Molecular Biology Core and an Immunoassay Core, (3) increasing the yearly amount of pilot/feasibility funding, and (4) adding nine new members to the Center with the purpose of further developing research in molecular biology. The unifying theme of research that has emerged from this Center is the study of the interaction between intestinal mesenchymal elements (immune cells, fibroblasts, endothelium and muscle) and the epithelial in the regulation of intestinal water and electrolyte transport, epithelial barrier functions and epithelial growth, development and repair. Proposed new P/F studies include investigation into: the expression of novel cytokines in the intestine in inflammatory bowel disease, the biochemistry of the intestinal extracellular matrix, mechanisms of intestinal potassium transport in rotavirus enteritis and the role of platelet activating factor as a neuromodulator of the enteric nervous system. The questions to be asked and answered by research in this Center are central to the prophylaxis and therapy of gastrointestinal acid-peptic diseases, cancer, infectious and functional diarrheas and inflammatory bowel disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK034987-07
Application #
3102070
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Project Start
1989-12-01
Project End
1994-11-30
Budget Start
1992-02-15
Budget End
1992-11-30
Support Year
7
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
Schools of Medicine
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Rolston, Vineet S; Boroujerdi, Laleh; Long, Millie D et al. (2018) The Influence of Hormonal Fluctuation on Inflammatory Bowel Disease Symptom Severity-A Cross-Sectional Cohort Study. Inflamm Bowel Dis 24:387-393
Eaton, Kathryn; Pirani, Ali; Snitkin, Evan S et al. (2018) Replication Study: Intestinal inflammation targets cancer-inducing activity of the microbiota. Elife 7:
Dong, Jing; Levine, David M; Buas, Matthew F et al. (2018) Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett's Esophagus. Clin Gastroenterol Hepatol 16:1598-1606.e4
Truax, Agnieszka D; Chen, Liang; Tam, Jason W et al. (2018) The Inhibitory Innate Immune Sensor NLRP12 Maintains a Threshold against Obesity by Regulating Gut Microbiota Homeostasis. Cell Host Microbe 24:364-378.e6
Palacios, Michelle; Miner, Taryn A; Frederick, Daniel R et al. (2018) Identification of Two Regulators of Virulence That Are Conserved in Klebsiella pneumoniae Classical and Hypervirulent Strains. MBio 9:
Williamson, Ian A; Arnold, Jason W; Samsa, Leigh Ann et al. (2018) A High-Throughput Organoid Microinjection Platform to Study Gastrointestinal Microbiota and Luminal Physiology. Cell Mol Gastroenterol Hepatol 6:301-319
Zhang, Cun-Jin; Wang, Chenhui; Jiang, Meiling et al. (2018) Act1 is a negative regulator in T and B cells via direct inhibition of STAT3. Nat Commun 9:2745
Evon, Donna M; Golin, Carol E; Ruffin, Rachel et al. (2018) Novel patient-reported outcomes (PROs) used in a pilot and feasibility study of a Cognitive Behavioral Coping Skills (CBCS) group intervention for patients with chronic hepatitis C. Pilot Feasibility Stud 4:92
Busch, Evan L; Don, Prabhani Kuruppumullage; Chu, Haitao et al. (2018) Diagnostic accuracy and prediction increment of markers of epithelial-mesenchymal transition to assess cancer cell detachment from primary tumors. BMC Cancer 18:82
Herfarth, Hans; Barnes, Edward L; Valentine, John F et al. (2018) Methotrexate Is Not Superior to Placebo in Maintaining Steroid-Free Response or Remission in Ulcerative Colitis. Gastroenterology 155:1098-1108.e9

Showing the most recent 10 out of 944 publications